VeriMom¿Es sh-tetrapeptide-38 trifluoroacetate seguro durante el embarazo?
No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
Related ingredients
Frequently asked questions
- ¿Es sh-tetrapeptide-38 trifluoroacetate seguro durante el embarazo?
- No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
- ¿Es sh-tetrapeptide-38 trifluoroacetate seguro durante la lactancia?
- No data found indicating systemic exposure, transfer into breastmilk, or lactation toxicity. Given the lack of reproductive or developmental hazard data and expected low dermal absorption of short peptides, exposure via breastmilk is considered negligible for topical cosmetic use (sources searched: SCCS/CIR, PubMed, PubChem, CosIng, ECHA).
- ¿Es sh-tetrapeptide-38 trifluoroacetate seguro para la piel del bebé?
- No infant‑specific reproductive or toxicity data found. Mechanistic/toxic effects not identified. Exposure rating increased by +1 for baby skin relative to adults because infants have an immature skin barrier and higher surface‑area‑to‑weight ratio; although adult dermal absorption is considered negligible, infant exposure is plausibly low but measurable for topical application. No evidence found of specific hazard to infants aged 0–3 years (sources searched: PubMed, CosIng, ECHA, PubChem, EWG).
- ¿Cómo puntúa VeriMom a sh-tetrapeptide-38 trifluoroacetate?
- VeriMom puntúa sh-tetrapeptide-38 trifluoroacetate en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a sh-tetrapeptide-38 trifluoroacetate en el embarazo?
- Consulta nuestra lista de alternativas seguras a sh-tetrapeptide-38 trifluoroacetate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.